Drug intelligence / Profile preview

Astracitron Phyto

Development stage
Unknown
Lead developer
Astrapharm
Modality
Small Molecules
Administration
Oral
01

Overview

Astracitron Phyto is a herbal dietary supplement developed and manufactured by the Ukrainian pharmaceutical company Astrapharm. It is formulated as a powder in sachets for the preparation of an oral solution. The product is designed to support the immune system and improve the functional state of the upper respiratory tract during seasonal viral infections and colds. Its composition typically includes a blend of plant extracts, such as ginger root (Zingiber officinale), linden blossom (Tilia cordata), elderberry fruit (Sambucus nigra), and rosehip (Rosa canina), supplemented with Vitamin C (ascorbic acid). These ingredients provide a combination of antioxidant, anti-inflammatory, and diaphoretic properties, helping to alleviate symptoms associated with respiratory distress and boosting the body's natural defenses. Unlike the standard Astracitron product line, the Phyto version does not contain synthetic analgesic or antipyretic agents like paracetamol.

Brand names
Astracitron Phyto
Other names
Астрацитрон Фіто
02

Targets

PLA2 (Phospholipase A2 group IID)15-LOX (Lysyl Oxidase)ALOX12 (Arachidonate 12-lipoxygenase, 12S type)CYP3A4 (Cytochrome P450 3A4)

Beyond the preview

Go deeper on Astracitron Phyto.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astracitron Phyto.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call